CARMI, Caterina
 Distribuzione geografica
Continente #
EU - Europa 770
NA - Nord America 727
AS - Asia 305
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.827
Nazione #
US - Stati Uniti d'America 710
CN - Cina 227
FI - Finlandia 188
SE - Svezia 136
IE - Irlanda 130
IT - Italia 128
DE - Germania 76
UA - Ucraina 66
TR - Turchia 28
AT - Austria 25
CI - Costa d'Avorio 24
SG - Singapore 22
IN - India 21
CA - Canada 17
BE - Belgio 12
CZ - Repubblica Ceca 6
JP - Giappone 2
KR - Corea 2
VN - Vietnam 2
EU - Europa 1
GB - Regno Unito 1
IR - Iran 1
LU - Lussemburgo 1
RO - Romania 1
Totale 1.827
Città #
Chandler 161
Dublin 130
Jacksonville 89
Parma 77
Ann Arbor 68
Dearborn 54
Beijing 49
Ashburn 43
Shanghai 36
Boardman 34
Nanjing 29
Izmir 27
San Mateo 27
Vienna 25
Abidjan 24
Princeton 23
New York 22
Wilmington 17
Pune 15
Toronto 15
Helsinki 14
Shenyang 14
Bremen 13
Kunming 12
Brussels 11
Hefei 11
Los Angeles 11
Hebei 10
Nanchang 10
Düsseldorf 9
Singapore 8
Jinan 7
Prata Di Pordenone 7
Tianjin 7
Brno 6
Des Moines 5
Ardea 4
Changsha 4
Jiaxing 4
Montegaldella 4
Fremont 3
Fuzhou 3
Seattle 3
Zhengzhou 3
Augusta 2
Borås 2
Dong Ket 2
Highland Park 2
Houston 2
Lübeck 2
Milan 2
Norwalk 2
Reggio Nell'emilia 2
Ulsan 2
Xian 2
Ankara 1
Atlanta 1
Braunschweig 1
Caorso 1
Casalgrande 1
Chengdu 1
Chongqing 1
Chuxiong 1
Dallas 1
Esslingen am Neckar 1
Fornovo Di Taro 1
Frankfurt am Main 1
Geislingen an der Steige 1
Grafing 1
Guangzhou 1
Haikou 1
Hangzhou 1
Huzhou 1
Lanzhou 1
Leuven 1
Lissone 1
Luxembourg 1
Montreal 1
Mumbai 1
Munich 1
Ningbo 1
Quzhou 1
Redmond 1
Rome 1
Sassuolo 1
Taizhou 1
Taranto 1
Tokyo 1
Utsunomiya 1
Woodbridge 1
Totale 1.205
Nome #
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 133
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 106
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides. 102
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 99
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 90
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 89
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability 87
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 86
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 86
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 83
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 81
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. 80
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives. 78
Clinical perspective for irreversible tyrosine kinase inhibitors in cancer 76
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands 73
New strategies to overcome resistance to EGFR tyrosine kinase inhibitors in non small cell lung cancer 70
Irreversible EGFR inhibitor compounds with antiproliferative activity 68
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 67
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion 66
Mannich base derivatives as novel EGFR irreversible inhibitors 57
Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors 52
Solution Phase Parallel Synthesis of S-DABO Analogues 49
Parallel Solution-Phase Synthesis of 1,5-disubstitued Hydantoins as New Protein Tyrosine Kinase Inhibitors 42
Parallel Solution-phase and Microwave-assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 39
Totale 1.859
Categoria #
all - tutte 6.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 18 2 28 37 46 8 27 26 9 23
2020/2021221 1 18 30 2 34 12 28 8 35 10 27 16
2021/2022144 6 9 5 7 7 2 22 23 7 13 10 33
2022/2023576 58 73 45 53 60 67 5 33 157 3 15 7
2023/2024192 12 11 1 5 12 60 22 14 5 9 14 27
2024/202554 28 26 0 0 0 0 0 0 0 0 0 0
Totale 1.859